Annals of Clinical and Translational Neurology (Oct 2019)

Validation of a self‐completed Dystonia Non‐Motor Symptoms Questionnaire

  • Lisa Klingelhoefer,
  • Kallol R. Chaudhuri,
  • Christoph Kamm,
  • Pablo Martinez‐Martin,
  • Kailash Bhatia,
  • Anna Sauerbier,
  • Maximilian Kaiser,
  • Carmen Rodriguez‐Blazquez,
  • Bettina Balint,
  • Robert Untucht,
  • Lynsey J. Hall,
  • Lauritz Mildenstein,
  • Miriam Wienecke,
  • Davide Martino,
  • Olaf Gregor,
  • Alexander Storch,
  • Heinz Reichmann

DOI
https://doi.org/10.1002/acn3.50900
Journal volume & issue
Vol. 6, no. 10
pp. 2054 – 2065

Abstract

Read online

Abstract Objective To develop and validate a novel 14‐item self‐completed questionnaire (in English and German) enquiring about the presence of non‐motor symptoms (NMS) during the past month in patients with craniocervical dystonia in an international multicenter study. Methods The Dystonia Non‐Motor Symptoms Questionnaire (DNMSQuest) covers seven domains including sleep, autonomic symptoms, fatigue, emotional well‐being, stigma, activities of daily living, sensory symptoms. The feasibility and clinimetric attributes were analyzed. Results Data from 194 patients with CD (65.6% female, mean age 58.96 ± 12.17 years, duration of disease 11.95 ± 9.40 years) and 102 age‐ and sex‐matched healthy controls (66.7% female, mean age 55.67 ± 17.62 years) were collected from centres in Germany and the UK. The median total NMS score in CD patients was 5 (interquartile range 3–7), significantly higher than in healthy controls with 1 (interquartile range 0.75–2.25) (P < 0.001, Mann–Whitney U‐test). Evidence for intercorrelation and convergent validity is shown by moderate to high correlations of total DNMSQuest score with motor symptom severity (TWSTRS: rs = 0.61), clinical global impression (rs = 0.40), and health‐related quality of life measures: CDQ‐24 (rs = 0.74), EQ‐5D index (rs = −0.59), and scale (rs = −0.49) (all P < 0.001). Data quality and acceptability was very satisfactory. Interpretation The DNMSQuest, a patient self‐completed questionnaire for NMS assessment in CD patients, appears robust, reproducible, and valid in clinical practice showing a tangible impact of NMS on quality of life in CD. As there is no specific, comprehensive, validated tool to assess the burden of NMS in dystonia, the DNMSQuest can bridge this gap and could easily be integrated into clinical practice.